ScholarWorks@Hanyang University: Choi, Ho Soon

Detailed Information

Choi, Ho Soon (최호순)

COLLEGE OF MEDICINE (DEPARTMENT OF INTERNAL MEDICINE)

Research Area

Tel 02-2290-8379
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Complications:5||irritable bowel syndrome:4||Guideline:4||Portal venous gas:4||s disease:4||Endoscopic ultrasound:4||Perforation:4||Pancreatic solid tumor:4||Obesity:4||Telemedicine:4||Technique:4||Crohn&apos:4||Gastric cancer:4||Endoscopy:3||Carcinoid tumor:3||Colon cancer:3||Insulin resistance:3||Duodenum:3||Gastroesophageal reflux:3||Pancreas:3||prevalence:3||Ischemic colitis:3||Korea:3||Leptin:3||Esophageal varices:2||DA9701:2||Colon:2||Adefovir dipivoxil:2||Small bowel villous atrophy:2||Colon metastasis:2||Medical education:2||Platelet count:2||Dietary habit:2||Colonic adenoma:2||Carcinosarcoma:2||Celiac disease:2||Subtypes:2||AntiTNFα:2||Neoplasm metastasis:2||Nephrotoxicity:2||Hepatitis B virus:2||Network:2||erosive esophagitis:2||Polymorphism:2||Biliary cast:2||Tissue:2||Tissues:2||Intraductal papillary mucinous neoplasm of the bile ducts:2||End stage renal disease:2||Treatment guidelines:2||원격진료:2||Liver:2||Tuberculosis:2||p53:2||Quality of life:2||Biliary fistula:2||Osteomalacia:2||Irritable bowel syndrome:2||의학교육:2||Lipoma:2||Predictive factors:2||Protein losing enteropathy:2||Probability(P)value:2||Lung cancer:2||Appendicitis:2||Pancreatitis:2||3상시험:2||Adenomatous polyps:2||Liver transplantation:2||Adenocarcinoma:2||Pseudocyst:2||췌장:2||Rectal accommodation:2||네트워크:2||Recurrence:2||Revaprazan:2||대장암:2||Rheumatic disease:2||레바프라잔:2||Risk factors:2||Hypophosphatemia:2||Ghrelin:1||HBV:1||Helicobacter pylori:1||Hemoclipping:1||Hepatitis B:1||Hepatocellular carcinoma:1||Hydrogen:1||Ileum:1||Ileus:1||Infection:1||Inflammatory bowel disease:1||Insulin:1||International educational exchange:1||Internet:1||Intestinal Gas:1||Intestinal permeability:1||Intestinal tuberculosis:1||Intraabdominal fat:1||Intraductal papillary mucinous neoplasm (IPMN):1||Intussusception:1||Iron deficiency anemia:1||Irritable Bowel Syndrome:1||Korean:1||Kupffer cells:1||Lactobacillus:1||Lactulose Breath Test:1||Leaky gut syndrome:1||Leptin receptor:1||Lipid partitioning:1||Lipotoxicity:1||Liver cirrhosis:1||Lunch:1||Lymph node:1||MUC3:1||MUC5B:1||Mesenteric veins:1||Metastasis:1||Methane:1||Model bile acid:1||Mucinous adenocarcinoma:1||Muscle mass:1||N200:1||Nanoparticle:1||Natural killer like T cells lymphoma:1||Necroptosis:1||Necrosis:1||Neoplasm:1||Nonalcoholic fatty liver:1||Nonalcoholic steatohepatitis:1||Nonerosive Reflux Disease:1||Nonobese:1||Nonalcoholic steatohepatitis:1||Omeprazole:1||P300:1||Pancreatic ducts:1||Pancreatic neoplasms:1||Pancreatiti:1||Peptic ulcer bleeding:1||Percutaneous endoscopic gastrostomy:1||Phosphorylated extracellular signalregulated kinase:1||Phytosterol:1||Postcholecystectomy syndrome:1||Prevalence:1||Probiotics:1||Proctitis:1||Prognosis:1||Proton pump inhibitor:1||Pseudomembranous colitis:1||Psoas abscess:1||Psychological test:1||P값:1||Ranitidine:1||Receptorinteracting protein kinase:1||Receptors:1||Rectal:1||STAT3:1||Safety:1||Sarcopenia:1||Sclerosis:1||Skeletal muscle index:1||Small intestinal injury model:1||Sorafenib:1||Sphincterotomy, endoscopic:1||Sphingosine phosphate:1||Steroid:1||Stomach cancer:1||Sulfasalazine:1||Survival rate:1||TGF:1||Telbivudine:1||Therapeutic endoscopy:1||Thioctic acid:1||Transdermal delivery system:1||Transport:1||Treatment outcome:1||Tubulointerstitial nephritis:1||Tumor lysis syndrome:1||Tumor necrosis factoralpha:1||Tyrosine kinase inhibitor:1||Ulcerative colitis:1||Upper gastrointestinal endoscopy:1||Variant angina:1||Vascular calcification:1||Vascular endothelial growth factor inhibitor:1||Visceral Obesity:1||Visceral fat area:1||Visceral hypersensitivity:1||Young:1||abdominal obesity:1||acute:1||adhesion:1||alanine aminotransferase:1||antibacterial agents:1||ascites:1||aspartate aminotransferase:1||caffeine:1||capecitabine:1||carnitine:1||cell separation:1||chest wall:1||chronic:1||chronic liver disease:1||circulating tumor cell:1||colon cancer:1||computed tomographic colonoscopy:1||constipation:1||dyspepsia:1||endoscopic surgery:1||fat:1||fibrosis:1||food allergy:1||gallbladder:1||gallstone:1||gastroesophageal reflux disease:1||gastroscopy:1||gemcitabine:1||ghrelin:1||grading:1||guamerin:1||hepatic encephalopathy:1||hepatic stellate cell:1||hepatocellular carcinoma:1||interleukin6:1||intestinal permeability:1||lactic acidosis:1||leptin:1||leukocyte elastase inhibitor:1||lipotoxicity:1||liver:1||liver fibrosis:1||magnetic resonance spectroscopy:1||malignancy:1||mast cell:1||measurement:1||metastasis:1||microbiota:1||microfluidics:1||minimal hepatic encephalopathy:1||mitochondria:1||mortality:1||network:1||nonHodgkin’s lymphoma:1||nonalcoholic fatty liver disease:1||normal:1||overall survival:1||pancreatic cancer:1||pancreatic neuroendocrine tumors:1||pancreatitis:1||peroxisome proliferatoractivated receptor (PPAR):1||populationbased:1||probiotic:1||probiotics:1||prognosis:1||progressionfree survival:1||propranolol:1||proton density fat fraction:1||psychometric hepatic encephalopathy score:1||rates:1||risk factors:1||sacute:1||sarpogrelate:1||sclerosing cholangitis:1||screening:1||selfreported constipation:1||size:1||skin prick test:1||small intestinal bacterial overgrowth:1||staging:1||stellate cell:1||stomach cancer:1||substance P:1||telemedicine:1||tenofovir disoproxil fumarate:1||treatment:1||tumor necrosis factoralpha:1||vasoactive intestinal peptide:1||visceral fat:1||volume:1||가족성샘종폴립증:1||간질성 신염:1||골연화증:1||급성 췌장염:1||나노입자:1||낭성:1||담관 내 점액성 유두 종양:1||대장:1||라니티딘:1||렙틴:1||만성 B형간염:1||만성 췌장염:1||말기신질환:1||모델 담즙산:1||바터 팽대부:1||복수:1||삶의 질:1||상부 위장관 내시경:1||생존율:1||선암종:1||선종:1||선종성 용종:1||스핑고신포스페이트:1||식도 정맥류:1||식도 천공:1||식습관:1||신독성:1||심부 경부감염증:1||심재성 낭종성 장염:1||십이지장:1||십이지장 종양:1||아데포비어:1||암육종:1||양자 펌프 억제제:1||예측인자:1||예후:1||오메프라졸:1||위 선암:1||위궤양:1||위막성 대장염:1||위식도역류질환:1||위염:1||위용종:1||위험요인:1||이상 반응:1||자가면역성 췌장염:1||저인산염혈증:1||젊은:1||조기 진단:1||종양:1||지방종:1||지혈클립:1||철 결핍성 빈혈:1||총담관십이지장 누공:1||출혈성 궤양:1||췌관내유두상점액종양:1||췌장암:1||췌장염:1||치료반응:1||텔비부딘:1||피부전달체:1||피테스테롤:1||한국:1||허혈성 대장염:1||磷酸鞘氨醇，植物甾醇，模拟胆汁酸，纳米粒子，皮肤传达体:1||혈소판수:1||5HT:1||5HT2A receptor:1||5aminosalicylate:1||ABCA1:1||ABCG5:1||ABCG8:1||ATPbinding cassette transporter A1 (ABCA1):1||Acute pancreatitis:1||Adenoma:1||Adverse effect:1||Adverse event:1||Afternoon colonoscopy:1||Alanine aminotransferase:1||Ampulla of Vater:1||Ampullary adenoma:1||Anatomy:1||Ascites:1||Aspartate aminotransferase:1||Autoimmune pancreatitis:1||Azathioprine:1||Behcet’s disease:1||Biology:1||Bowel preparation:1||Cameron ulcer:1||Cameron 궤양:1||Capassisted colonoscopy:1||Carbohydrate:1||Cell death:1||Chemical and drug induced liver injury:1||Cholangiocyte:1||Cholangiopathy:1||Cholesterol:1||Clinical Trial:1||Clinical outcome:1||Clinical trial phase III:1||Cold snare polypectomy:1||Colorectal cancer:1||Colorectal distension:1||Colorectal polyp:1||Common bile duct:1||Common bile duct stones:1||Coronary artery vasospasm:1||Corydalis:1||Crohn’s disease:1||Cyst:1||Cysts:1||DA6034:1||Deep neck infection:1||Diagnosis:1||Diet:1||Digital video transport system:1||Diverticulitis:1||Duodenal neoplasms:1||ERK1/2:1||Endstage renal disease:1||Endoscopic mucosal resection:1||Endoscopic papillectomy:1||Endoscopic treatment:1||Endoscopic ultrasoundguided fineneedle aspiration:1||Endosonography:1||Enteritis:1||Eosphagitis:1||Erosive Esophagitis:1||Esophageal perforation:1||Eventrelated potentials:1||Familial adenomatous polyposis:1||Followup studies:1||GIST (gastrointestinal stromal tumors):1||Gallbladder epithelial cell:1||Gallstone:1||Gallstone diseases:1||Gallstones:1||Gastric polyp:1||Gastric ulcer:1||Gastritis:1||Gastrointestinal diseases:1||Gastrointestinal endoscopy:1||Gastrointestinal stromal tumors:1||Gastrointestinal transit:1||Gastrostomy:1||

STATISTICS: Total View :4,961,969; Today View :777

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE